Raj Shamani's Figuring Out
Raj Shamani's Figuring Out

Billion-Dollar Founder: Why Success In India Is So Hard | Kiran Mazumdar-Shaw | FO537 Raj Shamani

July 18, 2026

AI Summary

5 min read

Kiran Mazumdar-Shaw, founder of Biocon, says she has never experienced self-doubt. Not once. This is not a boast but a direct consequence of how she operates: clarity of purpose, she argues, crowds out the mental space for doubt. In a conversation with Raj Shamani, she walks through the psychology behind that claim, the mechanics of building a global biotech company from a Bangalore garage, and the specific conditions under which her approach works—along with its limits.

The Mechanism of Confidence: Purpose Over Personality

Mazumdar-Shaw’s central psychological insight is that confidence is not a personality trait you are born with but a byproduct of clarity. “If you have clarity of thought and vision, and you're only focusing on executing that vision or that purpose, then I think you don't have self-doubt,” she says. The opposite is also true: when you are “approximating all the time and hoping that things will go right,” panic sets in the moment something goes wrong.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

What you'll learn

  • 1 (00:00) **Clarity Kills Self-Doubt** - Kiran introduces the central thesis of the episode: purpose-driven clarity eliminates self-doubt.
  • 2 (02:44) **A Charmed Childhood & A Father's Values** - Kiran describes how her liberal upbringing and father's principles shaped her character.
  • 3 (08:47) **The Rejection That Launched a Company** - Kiran details the gender bias she faced when trying to get a job as a brewer in India.
  • 4 (16:43) **The Accidental Entrepreneur & The License Raj** - Kiran recounts her leap into entrepreneurship and the immediate challenge of navigating India's bureaucratic system.
  • 5 (25:53) **The Power of Narrative: Getting People Excited** - Kiran explains how she secured her first loan by telling a compelling story, a key entrepreneurial skill.
  • 6 (30:03) **Reinventing the Business: From Enzymes to Insulin** - Kiran describes her strategic shift from enzymes to biopharma, driven by a desire to solve a national health crisis.
  • 7 (34:00) **From Insulin to Cancer: The Biosimilar Mission** - Kiran explains how a personal tragedy led her to tackle the high cost of cancer drugs.

+ Full timestamped outline available in the app

Guests on this episode

Show Notes

Get your hand-picked playbook here: ⁠⁠⁠https://www.figuringout.co/link/fo-537



Guest Suggestion Form:

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://forms.gle/bnaeY3FpoFU9ZjA47⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠



Disclaimer: This video is intended solely for educational purposes and opinions shared by the guest are his personal views. We do not intent to defame or harm any person/ brand/ product/ country/ profession mentioned in the video.



Our goal is to provide information to help audience make informed choices. The media used in this video are solely for informational purposes and belongs to their respective owners.




(00:00) - Intro
(02:37) - Childhood, Family Values & Father's Life Lesson on Merit
(07:41) - Rejected by Breweries for Being a Woman
(12:29) - Gender Bias in Funding & Starting Biocon Against All Odds
(27:08) - The Art of Pitching: Telling Your Story Right
(29:57) - From Enzymes to Pharma: Cracking Statins
(31:15) - The Insulin Breakthrough That Disrupted Global Pricing
(34:18) - Entering Cancer Biosimilars After Losing a Friend
(40:29) - Why Being First (Not Just Best) Matters
(43:52) - Building Affordable CAR-T Cancer Therapy (Immuneel)
(45:46) - The GLP-1 Weight-Loss Drug Debate
(53:13) - How Pharma Pricing & Margins Actually Work
(58:20) - A Near-Financial Crisis: The Loan Default Scare
(1:03:45) - How Can People Who Have Self-Doubt Build Confidence?
(1:07:13) - Why India Undervalues Innovation vs. the US
(1:13:51) - The AI Pathology Startup India Let Slip Away
(1:20:50) - Proving Global Pharma Giants Wrong
(1:26:43) - Bengaluru's Infrastructure & Civic Problems
(1:30:14) - India's Civic Sense Crisis
(1:35:44) - Why India Is Losing FDI to Vietnam & Indonesia
(1:38:03) - Has She Ever Felt Humiliated?
(1:41:58) - The Harshest Truth: Gender Bias in India
(1:50:51) - Big Pharma Ethics & COVID Vaccine Inequality
(1:55:52) - Choosing Her Successor: Niece Claire Mazumdar
(1:58:54) - The Power of Authentic Networking & Friendships
(2:02:47) - Separating Her Identity From Biocon
(2:04:52) - One Advice No One Should Follow
(2:06:03) - Outro


In today's episode, we sit down with Kiran Mazumdar-Shaw, Executive Chairperson of Biocon Limited, to talk about rejection, risk, and how she built India's biggest biotech company from a garage.



Follow Kiran Mazumdar-Shaw:

Instagram: Raj Shamani's Figuring Out